Carmot is using Chemotype Evolution to identify and optimize innovative drugs for
challenging therapeutic targets, thereby addressing important unmet chemical needs.
Carmot is applying a transformative technology, Chemotype Evolution, to overcome the limitations of conventional discovery technologies and to identify superior drug candidates for
challenging therapeutic targets.
Carmot is applying an innovative technology, Chemotype Evolution, to overcome the limitations of conventional discovery technologies and identify superior drug candidates for
challenging therapeutic targets.
Not exact matches
Although boosting the function of CRYAA and CRYAB seems to be a good
target, developing a
therapeutic has been
challenging.
Translating these into biological insights (or better yet,
therapeutic targets) has been
challenging.
The autoimmune
therapeutic area represents a broad category of human disease presentations that involve a variety of organ
targets and thus presents a significant
challenge with respect to the development of therapies designed to re-establish self - tolerance.
But the difficulties of producing long - lasting,
therapeutic RNA that remains stable and non-toxic while entering
targeted cells have posed
challenges for their progress.
A particular
challenge, one that could have important
therapeutic applications, is to design an antibody that binds with high affinity to a
target protein.